Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: The MIND randomized, placebo-controlled trial

Critical Care Medicine

Volumn 38, Issue 2, 2010, Pages 428-437

  Girard, Timothy D ^a,b,h   Pandharipande, Pratik P ^c,h   Carson, Shannon S ^c   Schmidt, Gregory A ^e   Wright, Patrick E ^f   Canonico, Angelo E ^g   Pun, Brenda T ^a   Thompson, Jennifer L ^c   Shintani, Ayumi K ^c   Meltzer, Herbert Y ^d   Bernard, Gordon R ^a   Dittus, Robert S ^b,h   Ely, E Wesley ^a,b,h  

^a Division of Allergy   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f MOSES H CONE MEMORIAL HOSPITAL   (United States)

^g SAINT THOMAS HOSPITAL   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antipsychotic agents; Clinical trial; Delirium; Haloperidol; Intensive care units; Ziprasidone

Indexed keywords

HALOPERIDOL; PLACEBO; ZIPRASIDONE;

ADULT; AGED; AKATHISIA; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; COMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DELIRIUM; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EXTRAPYRAMIDAL SYMPTOM; FEASIBILITY STUDY; FEMALE; HEART VENTRICLE ARRHYTHMIA; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 74949100313     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181c58715     Document Type: Article

References (47)

1. Ely EW, Shintani A, Truman B, et al: Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004; 291:1753-1762
2. Micek ST, Anand NJ, Laible BR, et al: Delirium as detected by the CAM-ICU predicts restraint use among mechanically ventilated medical patients. Crit Care Med 2005; 33: 1260-1265
3. Pandharipande P, Cotton BA, Shintani A, et al: Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma 2008; 65:34-41
4. Dubois MJ, Bergeron N, Dumont M, et al: Delirium in an intensive care unit: A study of risk factors. Intensive Care Med 2001; 27: 1297-1304
5. Ely EW, Gautam S, Margolin R, et al: The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med 2001; 27:1892-1900
6. Ouimet S, Kavanagh BP, Gottfried SB, et al: Incidence, risk factors and consequences of ICU delirium. Intensive Care Med 2007; 33: 66-73
7. Lin SM, Liu CY, Wang CH, et al: The impact of delirium on the survival of mechanically ventilated patients. Crit Care Med 2004; 32: 2254-2259
8. Milbrandt EB, Deppen S, Harrison PL, et al: Costs associated with delirium in mechanically ventilated patients. Crit Care Med 2004; 32:955-962
9. Inouye SK, Foreman MD, Mion LC, et al: Nurses' recognition of delirium and its symptoms: comparison of nurse and researcher ratings. Arch Intern Med 2001; 161: 2467-2473
10. Hustey FM, Meldon SW: The prevalence and documentation of impaired mental status in elderly emergency department patients. Ann Emerg Med 2002; 39:248-253
11. Jacobi J, Fraser GL, Coursin DB, et al: Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 2002; 30:119-141 (Pubitemid 34112188)
12. Ely EW, Stephens RK, Jackson JC, et al: Current opinions regarding the importance, diagnosis, and management of delirium in the intensive care unit: A survey of 912 healthcare professionals. Crit Care Med 2004; 32:106-112
13. Patel RL, Gambrell MA, Speroff T, et al: Delirium and sedation in the intensive care unit (ICU): Survey of behaviors and attitudes of 1,384 healthcare professionals. Crit Care Med 2009; 37:825-832
14. Skrobik YK, Bergeron N, Dumont M, et al: Olanzapine vs haloperidol: Treating delirium in a critical care setting. Intensive Care Med 2004; 30:444-449
15. Sharma ND, Rosman HS, Padhi ID, et al: Torsades de Pointes associated with intravenous haloperidol in critically ill patients. Am J Cardiol 1998; 81:238-240
16. Ray WA, Chung CP, Murray KT, et al: Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med 2009; 360: 225-235
17. Buckley NA, Sanders P: Cardiovascular adverse effects of antipsychotic drugs. Drug Saf 2000; 23:215-228
18. Adnet P, Lestavel P, Krivosic-Horber R: Neu-roleptic malignant syndrome. Br J Anaesth 2000; 85:129-135
19. Tandon R, Jibson MD: Extrapyramidal side effects of antipsychotic treatment: Scope of problem and impact on outcome. Ann Clin Psychiatry 2002; 14:123-129
20. Girard TD, Carson SS, Pandharipande PP, et al: The modifying the incidence of delirium (MIND) trial: A randomized controlled trial of the feasibility, efficacy, and safety of anti-psychotics for the prevention and treatment of ICU delirium. Am J Respir Crit Care Med 2008; 177:A817
21. Kay DWK: The epidemiology and identification of brain deficit in the elderly. In: Eisdor-fer C, Friedel RO, (Eds). Cognitive and Emotional Disturbance in the Elderly: Clinical
22. Issues. Chicago, IL, Year Book Medical Publishers, Inc., 1977; pp 11-26
23. Jorm AF, Jacomb PA: The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): Socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989; 19:1015-1022
24. Jorm AF: The Informant Questionnaire on cognitive decline in the elderly (IQCODE): A review. Int Psychogeriatr 2004; 16:275-293
25. Ely EW, Inouye SK, Bernard GR, et al: Delirium in mechanically ventilated patients: Validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA 2001; 286:2703-2710
26. Ely EW, Margolin R, Francis J, et al: Evaluation of delirium in critically ill patients: Validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med 2001; 29:1370-1379 (Pubitemid 32641799)
27. Ely EW, Pun BT: The Confusion Assessment Method for the ICU (CAM-ICU) training manual. Available online at: http://www.icudelirium.org/docs/CAM-ICU- training.pdf. Accessed November 4, 2009
28. Sessler CN, Gosnell MS, Grap MJ, et al: The Richmond Agitation-Sedation Scale: Validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002; 166:1338-1344
29. Ely EW, Truman B, Shintani A, et al: Monitoring sedation status over time in ICU patients: Reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA 2003; 289:2983-2991
30. Simpson GM, Angus JW: A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970; 212:11-19
31. Devanand DP, Marder K, Michaels KS, et al: A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease. Am J Psychiatry 1998; 155: 1512-1520
32. Suckow RF, Fein M, Correll CU, et al: Determination of plasma ziprasidone using liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 799:201-208
33. Schoenfeld DA, Bernard GR: Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 2002; 30:1772-1777
34. Pandharipande P, Shintani A, Peterson J, et al: Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 2006; 104: 21-26
35. Zeger SL, Liang KY: An overview of methods for the analysis of longitudinal data. Stat Med 1992; 11:1825-1839
36. Ihaka R, Gentleman R: R: a language for data analysis and graphics. J Comput Graph Stat 1996; 5:299-314
37. Moher D, Schulz KF, Altman DG: The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001; 134:657-662 (Pubitemid 32322244)
38. Trzepacz PT: Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsych 2000; 5:132-148
39. Meltzer HY, Matsubara S, Lee JC: Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther 1989; 251:238-246
40. Seeger TF, Seymour PA, Schmidt AW, et al: Ziprasidone (CP-88,059): A new antipsy-chotic with combined dopamine and serotonin receptor antagonist activity. J Pharmacol Exp Ther 1995; 275:101-113
41. Song C, Lin A, Kenis G, et al: Immunosup-pressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist. Schizophr Res 2000; 42: 157-164
42. Schetz JA, Perez E, Liu R, et al: A prototypical Sigma-1 receptor antagonist protects against brain ischemia. Brain Res 2007; 1181:1-9
43. Hu H, Deng W, Yang H: A prospective random control study comparison of olanzapine and haloperidol in senile delirium. Chongqing Med J 2004; 8:1234-1237
44. Kalisvaart KJ, de Jonghe JF, Bogaards MJ, et al: Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: A randomized placebo-controlled study. J Am Geriatr Soc 2005; 53:1658-1666
45. Inouye SK, Bogardus ST, Jr., Charpentier PA, et al: A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999; 340:669-676
46. Pandharipande PP, Pun BT, Herr DL, et al: Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: The MENDS randomized controlled trial. JAMA 2007; 298: 2644-2653
47. Riker RR, Shehabi Y, Bokesch PM, et al: Dexmedetomidine vs midazolam for sedation of critically ill patients: A randomized trial. JAMA 2009; 301:489-499